Nasdaq, Inc.
NDAQ
$91.57
+0.42%
Nasdaq, Inc. operates a diversified financial infrastructure and technology platform spanning three core segments: Capital Access Platforms (index and listing services), Market Technology (financial software, including the Verafin and Adenza acquisitions), and Market Services (equities and options trading). While globally recognized for its flagship U.S. equity exchange, the company has deliberately repositioned itself as a technology-first enterprise, with roughly 35% of revenue now derived from financial software and compliance solutions, distinguishing it from pure-play exchange operators like ICE or CME. The current investor narrative centers on this transformation, with recent news highlighting the SEC's approval of Nasdaq's tokenized settlement pilot and the adoption of 'fast entry' index rules that could accelerate inclusion of high-profile IPOs such as SpaceX, OpenAI, and Anthropic. These developments are fueling debate over whether Nasdaq can sustain premium software-like multiples while its legacy trading and listing businesses face cyclical and competitive pressures.…
NDAQ
Nasdaq, Inc.
$91.57
Related headlines
Investment Opinion: Should I buy NDAQ Today?
The synthesized recommendation is a Hold, balancing the stock's attractive forward valuation and strong cash flow against its decelerating revenue growth and significant relative underperformance. The analyst consensus is 'Buy' with a mean rating of 1.76 and an average target price of $109.67, implying 20.3% upside, but the wide target range ($84-$135) and the stock's 21.11% underperformance versus the S&P 500 over the past year suggest caution. The core thesis is that Nasdaq's transformation into a fintech company could unlock value, but execution risks and modest growth warrant a wait-and-see approach.
Supporting evidence for a Hold includes the forward PE of 19.5x, which is below the trailing PE of 31.0x and the fintech sector's typical 25-30x, suggesting the market expects a significant earnings ramp. Revenue growth is modest at 2.25% year-over-year, but profitability is improving, with net margin expanding to 24.3% from 18.9% and free cash flow of $2.004 billion (TTM) providing ample coverage for dividends and buybacks. The dividend yield of 1.08% with a payout ratio of 33.6% is sustainable, and the PEG ratio of 0.51 indicates undervaluation relative to growth expectations. However, the PB ratio of 4.53x and EV/EBITDA of 20.6x are not cheap, and the technology segment, while strategic, is the smallest at $517 million in quarterly revenue.
The biggest risks that could invalidate the thesis are: (1) failure to achieve the projected 109% earnings growth, which would likely compress the forward PE and lead to a de-rating; (2) continued revenue deceleration below 2%, which would undermine the growth narrative; and (3) integration missteps with Adenza and Verafin, which could pressure margins. The rating would upgrade to Buy if revenue growth accelerates above 5% and forward EPS estimates are met, or downgrade to Sell if revenue growth turns negative or margins contract significantly. Relative to its history, the stock is trading at the lower end of its valuation band (PE compressed from 40.4x in Q4 2023 to 31.0x), but it is not a deep-value play; it is fairly valued given the growth uncertainty.
Sign up to view all
NDAQ 12-Month Price Forecast
Nasdaq presents a balanced risk/reward profile with a neutral stance. The stock's forward valuation is attractive if the projected earnings ramp materializes, but decelerating revenue growth and significant relative underperformance raise concerns. The company's transformation into a fintech player offers long-term potential, but execution risks and competitive pressures are real. The analyst consensus is bullish, but the wide target dispersion and the stock's 21% underperformance versus the S&P 500 suggest the market is not fully convinced. I would upgrade to bullish if revenue growth accelerates above 5% and forward EPS estimates are met, and downgrade to bearish if revenue growth turns negative or margins contract significantly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Nasdaq, Inc.'s 12-month outlook, with a consensus price target around $109.67 and implied upside of +19.8% versus the current price.
Average Target
$109.67
0 analysts
Implied Upside
+19.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$84 - $135
Analyst target range
The stock is covered by 15 analysts with a consensus recommendation of 'Buy' and a recommendation mean of 1.76 on a scale where 1 is Strong Buy and 5 is Strong Sell, indicating a moderately bullish consensus. The average price target of $109.67 implies approximately 20.3% upside from the current price of $91.19, which is a meaningful premium that suggests analysts see the recent pullback as a buying opportunity rather than the start of a sustained downtrend. The consensus EPS estimate of $6.15 for the forward period aligns with the forward PE of 19.5x, and the estimated revenue average of $7.563 billion implies roughly 5-6% annual growth, consistent with the modest top-line trajectory observed in recent quarters. The target range spans from a low of $84.00 to a high of $135.00, a spread of $51.00 or 61% of the average target, which signals significant disagreement among analysts about the company's trajectory. The high target of $135 likely assumes successful integration of Adenza and Verafin, accelerating software revenue growth, multiple expansion toward fintech peers, and successful execution on tokenized settlement and fast-entry index initiatives. The low target of $84, which is 7.9% below the current price, likely prices in margin compression, slower-than-expected IPO activity, competitive pressure from rival exchanges, and a failure to realize synergies from recent acquisitions. Institutional ratings show a predominantly constructive tone, with Morgan Stanley, Raymond James, and Barclays maintaining Overweight or Outperform ratings as of July 2026, and TD Cowen upgrading from Hold to Buy in February 2026, though Keefe, Bruyette & Woods remains at Market Perform. The absence of any Sell ratings and the recent upgrade activity suggest that analyst sentiment is stable to improving, but the wide target spread and the stock's 21% underperformance versus the S&P 500 over the past year indicate that the market is not yet convinced the bullish thesis will play out.
Bulls vs Bears: NDAQ Investment Factors
The bear case currently has stronger evidence due to the stock's stark underperformance (-21.11% relative strength vs. SPY over one year) and decelerating revenue growth of just 2.25% year-over-year. However, the bull case rests on a compelling forward valuation (19.5x forward PE) and significant margin expansion, with net margin improving to 24.3% from 18.9%. The most critical tension is whether the projected 109% earnings growth (forward EPS of $6.15 vs. trailing EPS of $2.94) will materialize; if it does, the stock is deeply undervalued, but if integration and growth challenges persist, the premium multiples could compress further. Analyst consensus remains bullish with a $109.67 average target, but the wide dispersion ($84-$135) underscores the uncertainty. Near-term, the technical picture is neutral with the stock at $91.19, mid-range between $76.55 and $101.79, and recent momentum has turned negative (-4.67% over one month).
Bullish
- Attractive Forward Valuation: The forward PE of 19.5x is well below the trailing PE of 31.0x and the broader fintech sector's typical 25-30x range, implying a significant earnings ramp. The PEG ratio of 0.51 suggests the stock is undervalued relative to its expected growth, assuming the aggressive forward EPS estimate of $6.15 materializes.
- Strong Margin Expansion: Q1 2026 net margin expanded to 24.3% from 18.9% a year earlier, while gross margin improved to 65.8% from 39.0% (though the prior-year figure was distorted). Operating margin of 28.4% and EBITDA margin of 33.7% demonstrate operating leverage as integration costs normalize.
- Robust Free Cash Flow: Trailing twelve-month free cash flow is $2.004 billion, and Q1 2026 FCF of $629 million represents a 29.4% FCF margin. This comfortably covers the $153 million in dividends and $548 million in stock repurchases, supporting continued capital returns.
- Analyst Consensus Upside: The average analyst target of $109.67 implies 20.3% upside from the current price of $91.19, with 15 analysts maintaining a 'Buy' consensus (mean 1.76). The high target of $135 suggests significant optimism about the software transformation.
Bearish
- Severe Relative Underperformance: NDAQ has declined 4.89% over the past year while the S&P 500 gained 16.22%, resulting in a relative strength of -21.11%. This persistent underperformance suggests capital rotation away from the stock and raises concerns about its investment appeal.
- Decelerating Revenue Growth: Q1 2026 revenue grew only 2.25% year-over-year to $2.137 billion, a sharp deceleration from prior periods. The estimated revenue average of $7.563 billion implies just 5-6% annual growth, well below the tech sector average.
- Elevated Valuation on Some Metrics: The PB ratio of 4.53x and EV/EBITDA of 20.6x are high for a financial infrastructure firm, especially given modest growth. The PS ratio of 6.75x, while down from historical highs, still reflects a premium that may not be justified if growth stalls.
- Integration and Execution Risks: The $2.798 billion net cash outflow in Q1 2026, driven by $3.498 billion in other financing activities, raises questions about liquidity management. Successful integration of Adenza and Verafin is critical, but the technology segment remains the smallest at $517 million in quarterly revenue.
NDAQ Technical Analysis
Nasdaq shares are in a broad range-bound consolidation with a negative long-term tilt, having declined 4.89% over the past year while the S&P 500 gained 16.22%, resulting in a stark relative strength of -21.11%. The current price of $91.19 sits at approximately 58% of the 52-week range (low of $76.55 to high of $101.79), positioning it in the middle of its annual band rather than at an extreme. This neutral positioning suggests neither a clear momentum breakout nor a deep-value entry point, though the persistent underperformance relative to the broader market signals that capital is rotating elsewhere. Short-term momentum has deteriorated sharply, with a 1-month decline of 4.67% that contrasts with a positive 3-month gain of 2.48% and a 6-month gain of 6.62%. This divergence indicates that the stock rallied through the spring and summer but has recently lost steam, potentially forming a lower high after peaking near $99.47 in late August. The 1-month relative strength versus SPY is -3.61%, confirming that the recent pullback is stock-specific rather than market-driven, and the 2.25 short ratio suggests short sellers are not aggressively positioned, meaning the decline is likely driven by long-side selling rather than a coordinated bear raid. Key technical support rests at the 52-week low of $76.55, which also aligns with the June 2026 trough of $76.845, while resistance is established at the 52-week high of $101.79 and more immediately at the $99-$100 zone where the stock stalled in late August. A breakdown below $90 would likely accelerate selling toward the $85 area, whereas a breakout above $100 would require a fundamental catalyst to overcome the overhead supply. With a beta of 0.974, Nasdaq is slightly less volatile than the broader market, meaning its recent underperformance is not a function of high-beta risk but rather idiosyncratic weakness, which matters for portfolio managers seeking defensive exposure.
Beta
0.97
0.97x market volatility
Max Drawdown
-23.9%
Largest decline past year
52-Week Range
$77-$102
Price range past year
Annual Return
-2.5%
Cumulative gain past year
| Period | NDAQ Return | S&P 500 |
|---|---|---|
| 1m | -5.6% | -2.0% |
| 3m | +2.6% | +1.4% |
| 6m | +7.2% | +15.0% |
| 1y | -2.5% | +15.7% |
| ytd | -5.3% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NDAQ Fundamental Analysis
Nasdaq's revenue trajectory remains modestly positive but is decelerating, with Q1 2026 revenue of $2.137 billion representing just 2.25% year-over-year growth compared to Q1 2025's $2.09 billion. The sequential trend shows revenue dipping from $2.08 billion in Q4 2025 to $2.137 billion in Q1 2026, while the prior-year quarters ranged from $1.958 billion to $2.09 billion, indicating a plateau rather than an acceleration. Segment data reveals that Market Services generated $1.047 billion, Capital Access Platforms contributed $565 million, and Market Technology added $517 million, with the technology segment being the smallest despite being the strategic growth focus. The modest top-line growth implies that the investment case increasingly depends on margin expansion and capital returns rather than organic revenue acceleration, which raises the bar for execution on the Adenza and Verafin integrations. Profitability is robust, with Q1 2026 net income of $519 million on a 24.3% net margin, up from $395 million and an 18.9% net margin in Q1 2025, demonstrating meaningful year-over-year margin expansion. Gross margin stood at 65.8% in Q1 2026, a substantial improvement from 39.0% in Q1 2025, though the prior-year figure appears distorted by one-time cost classifications; the trailing twelve-month gross margin of 47.9% and operating margin of 28.4% are healthy for the financial infrastructure industry. EBITDA of $721 million in Q1 2026 yielded a 33.7% EBITDA margin, and the consistent improvement in net income ratio from 18.9% to 24.3% over four quarters signals that operating leverage is materializing as integration costs normalize. The balance sheet is sound but not fortress-like, with a debt-to-equity ratio of 0.81 and a current ratio of 1.005, indicating that short-term liquidity is adequate but not abundant. Free cash flow on a trailing twelve-month basis is $2.004 billion, and Q1 2026 free cash flow of $629 million represents a strong 29.4% FCF margin, comfortably covering the $153 million in dividends paid and $548 million in stock repurchases during the quarter. Return on equity of 14.6% and return on assets of 5.85% are respectable for a capital-intensive financial infrastructure firm, and the 1.08% dividend yield with a 33.6% payout ratio leaves ample room for continued capital returns. The primary risk is the $2.798 billion net cash outflow in Q1 2026, driven by $3.498 billion in other financing activities, which warrants monitoring to ensure it reflects debt management rather than liquidity stress.
Quarterly Revenue
$2.1B
2026-03
Revenue YoY Growth
+2.3%
YoY Comparison
Gross Margin
65.8%
Latest Quarter
Free Cash Flow
$2.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NDAQ Overvalued?
Because Nasdaq is profitable with positive net income of $519 million in Q1 2026, the PE ratio is the primary valuation metric, and the stock trades at a trailing PE of 31.0x versus a forward PE of 19.5x. This wide gap implies the market expects significant earnings growth, with forward EPS estimated at $6.15 versus trailing EPS of approximately $2.94, a 109% projected increase that likely reflects the normalization of integration costs and the full earnings contribution from recent acquisitions. The PEG ratio of 0.51 suggests that when adjusted for expected growth, the stock is undervalued relative to its earnings trajectory, though this metric is highly sensitive to the aggressive forward EPS estimate. On a peer comparison basis, the PS ratio of 6.75x and EV/EBITDA of 20.6x are moderate for a financial technology and exchange hybrid, though the PB ratio of 4.53x is elevated relative to traditional exchange operators. Without explicit industry average multiples in the provided data, we note that the forward PE of 19.5x is below the broader financial technology sector's typical 25-30x range, suggesting a discount that may reflect skepticism about the sustainability of the projected earnings ramp. The historical ratio data shows the PE ratio has compressed from 40.4x in Q4 2023 to 31.0x currently, and the PS ratio has declined from 19.3x to 6.75x over the same period, indicating that the stock is trading at the lower end of its own historical valuation band. This compression could signal either a value opportunity if earnings growth materializes as forecast, or a de-rating if the market is correctly anticipating structural growth challenges in the exchange and data businesses.
PE
31.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 20x~40x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.6x
Enterprise Value Multiple
Investment Risk Disclosure
Nasdaq faces financial risks stemming from its modest revenue growth and integration challenges. Revenue grew only 2.25% year-over-year in Q1 2026 to $2.137 billion, with the technology segment contributing just $517 million, the smallest of the three segments. The debt-to-equity ratio of 0.81 and current ratio of 1.005 indicate adequate but not fortress-like liquidity, and the $2.798 billion net cash outflow in Q1 2026, driven by $3.498 billion in other financing activities, warrants monitoring to ensure it reflects debt management rather than liquidity stress. Additionally, the company's profitability relies on margin expansion, with net margin at 24.3% and operating margin at 28.4%; any slowdown in cost synergies from Adenza and Verafin could pressure these levels.
Market and competitive risks include the stock's significant underperformance relative to the broader market, with a 1-year relative strength of -21.11% versus the S&P 500. The beta of 0.974 suggests the stock is slightly less volatile than the market, so its underperformance is idiosyncratic rather than driven by high-beta risk. Valuation compression is a concern: the trailing PE of 31.0x and PB of 4.53x are elevated for a financial infrastructure firm, and if growth fails to accelerate, multiples could contract. Competitive pressures from rival exchanges like ICE and CME, as well as emerging fintech platforms, could erode Nasdaq's market share, while regulatory changes (e.g., SEC's tokenized settlement pilot) introduce both opportunities and uncertainties.
In a worst-case scenario, a failure to realize the projected earnings ramp (forward EPS of $6.15 vs. trailing $2.94) could trigger a sharp de-rating. If revenue growth stalls below 2% and margins compress, the stock could fall to its 52-week low of $76.55, representing a 16.1% decline from the current price of $91.19. The analyst low target of $84 implies a 7.9% downside, but a more severe scenario—such as a recession reducing trading volumes and IPO activity—could push the stock toward the $76.55 support level, a loss of approximately 16%. The maximum drawdown over the past year was -23.9%, indicating that steeper declines are possible in adverse conditions.
FAQ
The key risks include: 1) Financial risk: revenue growth is decelerating, at just 2.25% year-over-year in Q1 2026, and the company has a debt-to-equity ratio of 0.81 with a current ratio of 1.005, indicating limited liquidity buffer. 2) Competitive risk: Nasdaq faces intense competition from rival exchanges like ICE and CME, as well as emerging fintech platforms, which could erode its market share in trading and listings. 3) Macro risk: with a beta of 0.974, the stock is slightly less volatile than the market, but an economic downturn could reduce trading volumes and IPO activity, impacting revenue. 4) Company-specific risk: integration of Adenza and Verafin may not deliver expected synergies, and the technology segment is still the smallest at $517 million in quarterly revenue. The most severe risk is a failure to achieve the projected earnings growth, which could lead to a sharp de-rating.
The 12-month forecast includes three scenarios: bull case (25% probability) with a target range of $120-$135, assuming successful integration and multiple expansion; base case (55% probability) with a target range of $100-$115, assuming steady growth and margin expansion; and bear case (20% probability) with a target range of $76-$84, assuming revenue stagnation and margin compression. The base case is most likely, with the key assumption that revenue grows 3-5% and net margin remains above 24%. The analyst average target of $109.67 aligns with the base case. The stock's current price of $91.19 is below all scenarios except the bear case, suggesting potential upside if the base case materializes.
NDAQ appears undervalued on a forward basis but fairly valued on trailing metrics. The forward PE of 19.5x is below the trailing PE of 31.0x and the broader fintech sector's typical 25-30x, suggesting the market expects significant earnings growth. The PEG ratio of 0.51 indicates undervaluation relative to growth, while the PS ratio of 6.75x and PB ratio of 4.53x are moderate for a financial infrastructure firm. Compared to its own history, the PE has compressed from 40.4x in Q4 2023 to 31.0x, placing it at the lower end of its valuation band. The market is pricing in a successful earnings ramp; if that fails, the stock could be overvalued at current levels.
From a risk/reward perspective, NDAQ is a moderate buy for patient investors. The stock trades at $91.19, with an average analyst target of $109.67 implying 20.3% upside, and a forward PE of 19.5x that is below the fintech sector average. However, the biggest downside risk is a failure to achieve the projected earnings growth, which could push the stock to its 52-week low of $76.55, a 16% decline. The company's strong free cash flow of $2.004 billion and improving net margin of 24.3% provide some downside protection. It is a good buy for those with a long-term horizon who believe in the fintech transformation, but near-term volatility and relative underperformance warrant caution.
NDAQ is more suitable for long-term investment due to its stable cash flows, dividend yield of 1.08%, and ongoing transformation into a fintech company. The stock has a beta of 0.974, indicating lower volatility than the market, and a dividend payout ratio of 33.6%, which is sustainable. However, near-term earnings visibility is moderate, with revenue growth decelerating and integration risks. Short-term trading could be challenging given the stock's recent 4.67% one-month decline and relative underperformance. A suggested minimum holding period is 2-3 years to allow for the realization of synergies and the earnings ramp. The stock is not a high-growth momentum play but a steady compounder for patient investors.